Columbia Laboratories (CBRX) Tops Q3 EPS by 22c

Columbia Laboratories (NASDAQ: CBRX) reported Q3 EPS of $0.34, $0.22 better than the analyst estimate of $0.12. Revenue for the quarter came in at $11.5 million versus the consensus estimate of $9.74 million.

For earnings history and earnings-related data on Columbia Laboratories (CBRX) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
• Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c